In This Section      
Print This Page

Pediatric Hematology & Oncology Fellowship

Johns Hopkins University/National Institute of Health Pediatric Hematology-Oncology Fellowship

The Johns Hopkins University School of Medicine and the National Cancer Institute represent two of the of the most distinguished pediatric hematology-oncology centers in the world, and their joint fellowship provides exceptional training to six new fellows per year. The program’s mission is to train diversely talented academic physician-scientists who will become leaders in the field of pediatric hematology-oncology.

The program is under the direction of Donald Small, MD, PhD, Sidney Kimmel Comprehensive Cancer Center's Pediatric Oncology Division Director and Fellowship Program Director, with Stacy Cooper, MD, Associate Program Director. Program leadership is additionally composed of National Cancer Institute fellowship co-directors Terry Fry, MD, and Nirali Shah, MD, and Clifford Takemoto, MD, Johns Hopkins Pediatric Hematology fellowship co-director. Gladys Valencia Novak and Vicki Richmond serve as fellowship program coordinators.

Fundamental Program Facets

  • Comprehensive training occurs through three complementary clinical exposures
  • Optimal clinical education is achieved by active patient care in a fellow-centric model
  • Protected research time essential for productive scholarship during years 2 and 3, and includes the option for a non-clinical, fully funded fourth year of research
  • World renowned experts in the field are committed to providing dedicated mentorship
  • Fellow wellness is actively promoted in a potentially emotionally challenging subspecialty 

Program Curriculum

The first year of fellowship is composed of 11 months of clinical training, rotating twice through each one-month block: 

curriculum

The second and third years of fellowship are dedicated to protected research time, with clinical requirements consisting solely of ½ day per week of longitudinal clinic and 4-5 weekends on inpatient hematology.

Many fellows chose to stay on for an optional fourth year of advanced training supported by the JHU T32 grant and NCI slots, which allows for additional dedicated research time as well as an opportunity for focused clinical training in a disease sub-specialty (bone marrow transplant, neuro-oncology, etc.).